If you need more lookups,
subscriptions start at $34 USD/month.
Steve Chin Location
Shanghai, CN
Steve Chin Work
Chief Medical Officer @ (October 2023 - Present)
Chief Medical Officer @ (January 2020 - October 2023)
Senior Medical Director, Immuno-Oncology, Global Clinical Development @ (May 2018 - January 2020)
Global and US GI Oncology Lead @ Eli Lilly and Company (December 2017 - May 2018)
US Medical Lead, GI and H and N Oncology @ Eli Lilly and Company (July 2014 - December 2017)
Assistant Professor @ (September 2008 - July 2014)
GI Medical Oncology @ Holling Cancer Center (September 2008 - July 2014)
Assistant Professor @ (July 2005 - September 2008)
Steve Chin Education
Penn State College of Medicine
Boston University
Wayne State University School of Medicine
Steve Chin Skills
Healthcare
Oncology
Clinical Research
Medicine
Life Sciences
Biotechnology
Medical Education
Internal Medicine
Cancer Research
Oncology Clinical Research
Clinical Trials
Drug Development
Pharmaceutical Industry
Biologics
Monoclonal Antibodies
Cancer Immunotherapy
Medical Writing
Targeted Therapies
Strategic Planning
Product Development
Clinical Development
Cancer
Research
Product Launch
Regulatory Submissions
Cross Functional Team Leadership
Sales
Cross Cultural Communication Skills
Drug Discovery
Steve Chin Summary
Steve Chin, based in Shanghai, CN, is currently a Chief Medical Officer at MediLink Therapeutics. Steve Chin brings experience from previous roles at Elpiscience Biopharmaceuticals, Inc., AstraZeneca and Eli Lilly and Company. Steve Chin holds a Penn State College of Medicine. With a robust skill set that includes Healthcare, Oncology, Clinical Research, Medicine, Life Sciences and more. Steve Chin has 5 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Steve Chin?
Find contact details for 700 million professionals.